NovAccess Global Announces New License to Advance its Immunotherapy Platform

Stock Information for Novaccess Global Inc

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Novaccess Global Inc

NovAccess Global Files Patent with Cedars-Sinai to Advance its Brain Cancer Fighting Vaccine Platform
NovAccess Global Advisory on Annual Meeting of Shareholders
NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders
NovAccess Global Announces $10.7 Million Financing
NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit
NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board
NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform
NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.